Paras Healthcare’s ₹1,450 crore initial public offering (IPO) entered its second day of public subscription today, October 22, 2026, with a price band of ₹660 to ₹693 per share. As of 10:27 AM on the second day of bidding, the issue had been subscribed 0.19 times.
The IPO will remain open for subscription until October 23, 2026. The allotment is expected to be finalised on October 26, 2026, while the shares are scheduled to list on the BSE and NSE on October 28, 2026.
The expected IPO schedule is as follows:
|
Event |
Date |
|
Subscription Opening Date |
21 October 2026 |
|
Subscription Closing Date |
23 October 2026 |
|
Basis of Allotment Date |
26 October 2026 |
|
Refund Initiation Date |
27 October 2026 |
|
Credit of Shares |
27 October 2026 |
|
Listing on BSE and NSE |
28 October 2026 |
Note: The allotment and listing dates are tentative and may be revised.
Explore other Upcoming IPOs on BSE and NSE.
[October 22, 2026, 10:00 A.M.]
|
Category |
Subscription (x) |
|
Qualified Institutional Buyers (QIBs) |
0.00x |
|
Non-Institutional Investors (NIIs) |
0.10x |
|
Retail Individual Investors (RIIs) |
0.88x |
|
Total |
0.19x |
The company intends to utilise the net proceeds from the fresh issue towards:
Founded in 1987, Paras Healthcare Limited operates eight hospitals under the Paras Health brand, with a combined capacity of 2,211 beds across North India, Bihar and Jharkhand. As of June 30, 2026, its network covered five states and one union territory.
The company plans to add 300 beds in Gurugram by FY2027 and 500 beds in Ludhiana by FY2028, increasing its total capacity to 3,011 beds by March 2028. Its key specialties include cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and renal sciences, which contributed 74.70% of its FY2026 revenue. As of June 30, 2026, it had 1,084 doctors and 1,937 nurses.
|
Particulars |
For the three month period ended June 30, 2026 (in ₹ crore) |
FY26 (in ₹ crore) |
FY25 (in ₹ crore) |
|
Revenue from operations |
470.28 |
1,605.95 |
1,294.06 |
|
EBITDA |
113.48 |
335.58 |
156.46 |
|
Profit After Tax (PAT) |
49.68 |
43.83 |
(57.98) |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here